Literature DB >> 11093907

Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat.

D Coss1, L Yang, C B Kuo, X Xu, R A Luben, A M Walker.   

Abstract

The purpose of the current study was to determine whether maternal prolactin (PRL) had any effects on bone formation in the developing rat pup. Because the most prevalent forms of PRL in rats are unmodified and phosphorylated PRL, both recombinant PRL and a molecular mimic of phosphorylated PRL (PP-PRL) were administered to pregnant animals. Blood samples from the dams showed normal estrogen and progesterone and no effect of extra PRL on parathyroid hormone (PTH), calcium, or alkaline phosphatase (AP). In newborn pups, however, there was a 30% decrease in blood AP in both PRL-treated groups, whereas PTH and calcium levels were not different from controls. When primary rat osteoblasts were exposed to both PRLs, AP activity was reduced, with PP-PRL being the more potent form of the hormone. Histological examination of pup bone formation showed reduced calvarial bone and reduced endochondral ossification in pups exposed to PP-PRL. These results are the first to show a direct inhibitory effect of PRL on osteoblast function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093907     DOI: 10.1152/ajpendo.2000.279.6.E1216

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  22 in total

1.  Possible chondroregulatory role of prolactin on the tibial growth plate of lactating rats.

Authors:  Panan Suntornsaratoon; Kannikar Wongdee; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  Histochem Cell Biol       Date:  2010-10-02       Impact factor: 4.304

2.  Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents.

Authors:  Chadi A Calarge; Stephanie D Ivins; Katherine J Motyl; Amal A Shibli-Rahhal; Michael M Bliziotes; Janet A Schlechte
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

3.  Prolactin alters the mRNA expression of osteoblast-derived osteoclastogenic factors in osteoblast-like UMR106 cells.

Authors:  Kannikar Wongdee; Warut Tulalamba; Jirawan Thongbunchoo; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  Mol Cell Biochem       Date:  2010-11-30       Impact factor: 3.396

4.  Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells.

Authors:  Changhui Deng; Eric Ueda; Kuanhui E Chen; Craig Bula; Anthony W Norman; Richard A Luben; Ameae M Walker
Journal:  Mol Endocrinol       Date:  2008-12-12

Review 5.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

6.  Expression of prolactin receptors in the duodenum, kidneys and skeletal system during physiological and sulpiride-induced hyperprolactinaemia.

Authors:  Danijela Radojkovic; Milica Pesic; Milan Radojkovic; Dragan Dimic; Marija Vukelic Nikolic; Tatjana Jevtovic Stoimenov; Sasa Radenkovic; Milena Velojic Golubovic; Tatjana Radjenovic Petkovic; Slobodan Antic
Journal:  Endocrine       Date:  2018-08-24       Impact factor: 3.633

7.  Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures.

Authors:  Gregory J Tranah; Brent C Taylor; Li-Yung Lui; Joseph M Zmuda; Jane A Cauley; Kristine E Ensrud; Teresa A Hillier; Marc C Hochberg; Jia Li; Brian K Rhees; Henry A Erlich; Mark D Sternlicht; Gary Peltz; Steven R Cummings
Journal:  Calcif Tissue Int       Date:  2008-09-12       Impact factor: 4.333

8.  Common and specific effects of the two major forms of prolactin in the rat testis.

Authors:  Valencia L Williams; Ariel DeGuzman; Hong Dang; Mitsumori Kawaminami; Timothy W C Ho; David G Carter; Ameae M Walker
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-02       Impact factor: 4.310

9.  Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment.

Authors:  Jeffrey R Bishop; Leah H Rubin; James L Reilly; Mani N Pavuluri; John A Sweeney
Journal:  Ther Adv Psychopharmacol       Date:  2012-06

Review 10.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.